Takeda Pharmaceutical acquires celiac disease drug developer PvP Biologics
Takeda acquisition of PvP Biologics : Japanese pharma giant Takeda Pharmaceutical Company has acquired US-based celiac disease drug developer PvP Biologics in a deal worth ... Read More
Towa Pharmaceutical acquires Pensa Investments from Esteve
Japanese pharma company Towa Pharmaceutical has wrapped up its previously announced €320 million acquisition of Pensa Investments - the generics division of Spanish pharma company ... Read More
Bacalhau oil field : Japanese firm MODEC wins FPSO contract from Equinor
MODEC has bagged a contract to deliver a floating production storage and offloading vessel (FPSO vessel) from Equinor Brasil Energia for the Bacalhau oil field ... Read More
Electric air mobility company AutoFlightX gets investment from TDK Ventures
Germany-based electric air mobility company AutoFlightX has secured investment from TDK Ventures, a subsidiary of Japanese electronics company TDK Corporation. AutoFlightX, which is engaged in ... Read More
Retail tech startup Accel Robotics raises $30m from SoftBank and others
California-based Accel Robotics, a retail tech startup which uses artificial intelligence (AI) and computer vision to provide checkout-free experience, has raised $30 million in a ... Read More
Astellas Pharma to acquire US gene therapy company Audentes Therapeutics
Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about ... Read More
Paidy instant buy-now pay later payment option now on Amazon.co.jp
Japanese fintech company Paidy said that its instant buy-now pay later payment service is now available on Amazon.co.jp as a payment option for customers. Paidy ... Read More
Novartis’ Sandoz to acquire Aspen’s Japanese pharma business
Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen ... Read More
Pandion bags $795m deal with Astellas for pancreas-targeted immunomodulators
Pandion Therapeutics has bagged a $795 million worth license and collaboration deal with Japanese pharma company Astellas Pharma for the research, development, and commercialization of ... Read More
Shiseido to acquire US prestige skincare brand Drunk Elephant
Shiseido acquisition of Drunk Elephant : Japanese personal care company Shiseido said that its US subsidiary - Shiseido Americas has agreed to acquire prestige skincare ... Read More